Previous gene expression screening suggested estrogen receptor expression may be increased by FZD9 loss and alterations in estrogen receptors have been associated with lung cancer, so we measured expression of estrogen receptor α (ESR1) and β (ESR2) (19). Here, FZD9 is linked to lung carcinoma.